Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589121 · ClinicalTrials.gov registry record · Phase 2
Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 98
- Enrollment target
NCT00589121 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 98 participants.
The verdict
NCT00589121, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 98 participants
- Enrollment target
Study Summary
RATIONALE: Image-guided radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a lower dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying the side effects and how well image-guided radiation therapy works in treating patients with primary soft tissue sarcoma of the shoulder, arm, hip, or leg.
Interventions
- DRUG Chemotherapy
- PROCEDURE Surgery
- RADIATION Radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2008-03 |
| Est. Completion | 2018-05-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589121
The ClinicalTrials.gov registry entry for NCT00589121 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Chemotherapy is the first listed.
NCT00589121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00589121 about?
NCT00589121 is a clinical study titled "Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg". RATIONALE: Image-guided radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a lower dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying the side effe...
What is the current status of trial NCT00589121?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 98 participants. The study started on 2008-03. Estimated completion is 2018-05-21.
What interventions are being tested in trial NCT00589121?
The interventions under investigation include: Chemotherapy (DRUG), Surgery (PROCEDURE), Radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00589121?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.